Revisión sistemática del uso terapéutico de células madre mesenquimales en enfermedades musculoesqueléticas o neurodegenerativas en caninos

In recent years there has been an increase in the presentation of cases in canines of musculoskeletal or neurodegenerative diseases, which leads to an impairment in the quality of life of the patient, who constantly manifest pain or have diminished motor skills, for this reason conducted a systemati...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autor: Cueva Recalde, Pedro José (author)
Médium: bachelorThesis
Jazyk:spa
Vydáno: 2019
Témata:
On-line přístup:http://dspace.udla.edu.ec/handle/33000/10990
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
_version_ 1862844296867086336
author Cueva Recalde, Pedro José
author_facet Cueva Recalde, Pedro José
author_role author
collection Repositorio Universidad de las Américas
dc.contributor.none.fl_str_mv Pesántez Valdivieso, Juan José
dc.creator.none.fl_str_mv Cueva Recalde, Pedro José
dc.date.none.fl_str_mv 2019-05-22T22:21:50Z
2019-05-22T22:21:50Z
2019
dc.format.none.fl_str_mv 59 p.
application/pdf
dc.identifier.none.fl_str_mv Cueva Recalde, P. J. (2019). “Revisión sistemática del uso terapéutico de células madre mesenquimales en enfermedades musculoesqueléticas o neurodegenerativas en caninos” (Tesis de pregrado). Universidad de las Américas, Quito.
UDLA-EC-TMVZ-2019-25
http://dspace.udla.edu.ec/handle/33000/10990
dc.language.none.fl_str_mv spa
dc.publisher.none.fl_str_mv Quito: Universidad de las Américas, 2019
dc.rights.none.fl_str_mv Atribución-NoComercial-SinDerivadas 3.0 Ecuador
http://creativecommons.org/licenses/by-nc-nd/3.0/ec/
info:eu-repo/semantics/openAccess
dc.source.none.fl_str_mv reponame:Repositorio Universidad de las Américas
instname:Universidad de las Américas
instacron:UDLA
dc.subject.none.fl_str_mv PATOLOGÍA MUSCULOESQUELÉTICA-CANINOS
CÉLULAS MADRE MESENQUIMALES
PRUEBA EXACTA DE FISHER
dc.title.none.fl_str_mv Revisión sistemática del uso terapéutico de células madre mesenquimales en enfermedades musculoesqueléticas o neurodegenerativas en caninos
dc.type.none.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/bachelorThesis
description In recent years there has been an increase in the presentation of cases in canines of musculoskeletal or neurodegenerative diseases, which leads to an impairment in the quality of life of the patient, who constantly manifest pain or have diminished motor skills, for this reason conducted a systematic review of the therapeutic use of mesenchymal stem cells (MSCs) in musculoskeletal and neurodegenerative diseases in studies conducted between 2008 and 2018 in English and Spanish in three web search engines such as Pub Med, Cochrane Plus Library and Science Direct , within which for the systematized search Mesh terms and boléanos markers were used to extend the search range and not lose information during the search stage. It is worth mentioning that for the realization of this systematic review, the PRISMA method checklist and the flow diagram were always used to complete all the stages contemplated by this methodology. At the same time, eligibility and exclusion criteria were included, in order to better define the search for the desired articles during the screening stage; being one of the main criteria of exclusion those articles in which the dogs have been evaluated as research models for diseases in humans. The data obtained were evaluated by Fisher's exact test, which showed that there is no significant relationship (p 0.5) between the origin of the MSCs and the type of disease evaluated. In conclusion, it was determined that the main stem cells used for the treatment of these pathologies are mesenchymal stem cells of adipose tissue (Ad MSCs) and mesenchymal stem cells of bone marrow (BM MSCs) that provide a significant improvement after application decreasing the sensation of pain.
eu_rights_str_mv openAccess
format bachelorThesis
id UDLA_31314c1924fc6d0039d025cece81210b
identifier_str_mv Cueva Recalde, P. J. (2019). “Revisión sistemática del uso terapéutico de células madre mesenquimales en enfermedades musculoesqueléticas o neurodegenerativas en caninos” (Tesis de pregrado). Universidad de las Américas, Quito.
UDLA-EC-TMVZ-2019-25
instacron_str UDLA
institution UDLA
instname_str Universidad de las Américas
language spa
network_acronym_str UDLA
network_name_str Repositorio Universidad de las Américas
oai_identifier_str oai:dspace.udla.edu.ec:33000/10990
publishDate 2019
publisher.none.fl_str_mv Quito: Universidad de las Américas, 2019
reponame_str Repositorio Universidad de las Américas
repository.mail.fl_str_mv .
repository.name.fl_str_mv Repositorio Universidad de las Américas - Universidad de las Américas
repository_id_str 2845
rights_invalid_str_mv Atribución-NoComercial-SinDerivadas 3.0 Ecuador
http://creativecommons.org/licenses/by-nc-nd/3.0/ec/
spelling Revisión sistemática del uso terapéutico de células madre mesenquimales en enfermedades musculoesqueléticas o neurodegenerativas en caninosCueva Recalde, Pedro JoséPATOLOGÍA MUSCULOESQUELÉTICA-CANINOSCÉLULAS MADRE MESENQUIMALESPRUEBA EXACTA DE FISHERIn recent years there has been an increase in the presentation of cases in canines of musculoskeletal or neurodegenerative diseases, which leads to an impairment in the quality of life of the patient, who constantly manifest pain or have diminished motor skills, for this reason conducted a systematic review of the therapeutic use of mesenchymal stem cells (MSCs) in musculoskeletal and neurodegenerative diseases in studies conducted between 2008 and 2018 in English and Spanish in three web search engines such as Pub Med, Cochrane Plus Library and Science Direct , within which for the systematized search Mesh terms and boléanos markers were used to extend the search range and not lose information during the search stage. It is worth mentioning that for the realization of this systematic review, the PRISMA method checklist and the flow diagram were always used to complete all the stages contemplated by this methodology. At the same time, eligibility and exclusion criteria were included, in order to better define the search for the desired articles during the screening stage; being one of the main criteria of exclusion those articles in which the dogs have been evaluated as research models for diseases in humans. The data obtained were evaluated by Fisher's exact test, which showed that there is no significant relationship (p 0.5) between the origin of the MSCs and the type of disease evaluated. In conclusion, it was determined that the main stem cells used for the treatment of these pathologies are mesenchymal stem cells of adipose tissue (Ad MSCs) and mesenchymal stem cells of bone marrow (BM MSCs) that provide a significant improvement after application decreasing the sensation of pain.En los últimos años ha existido un incremento en la presentación de casos, en caninos, de enfermedades musculoesqueléticas o neurodegenerativa, lo que conlleva a una afectación en la calidad de vida del paciente, que constantemente manifiestan dolor o ven disminuida sus habilidades motoras...Quito: Universidad de las Américas, 2019Pesántez Valdivieso, Juan José2019-05-22T22:21:50Z2019-05-22T22:21:50Z2019info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesis59 p.application/pdfCueva Recalde, P. J. (2019). “Revisión sistemática del uso terapéutico de células madre mesenquimales en enfermedades musculoesqueléticas o neurodegenerativas en caninos” (Tesis de pregrado). Universidad de las Américas, Quito.UDLA-EC-TMVZ-2019-25http://dspace.udla.edu.ec/handle/33000/10990spaAtribución-NoComercial-SinDerivadas 3.0 Ecuadorhttp://creativecommons.org/licenses/by-nc-nd/3.0/ec/info:eu-repo/semantics/openAccessreponame:Repositorio Universidad de las Américasinstname:Universidad de las Américasinstacron:UDLA2021-03-25T00:10:21Zoai:dspace.udla.edu.ec:33000/10990Institucionalhttps://dspace.udla.edu.ec/Universidad privadahttps://www.udla.edu.ec/https://dspace.udla.edu.ec/aoi.Ecuador...opendoar:28452026-04-18T19:25:57.976298Repositorio Universidad de las Américas - Universidad de las Américastrue
spellingShingle Revisión sistemática del uso terapéutico de células madre mesenquimales en enfermedades musculoesqueléticas o neurodegenerativas en caninos
Cueva Recalde, Pedro José
PATOLOGÍA MUSCULOESQUELÉTICA-CANINOS
CÉLULAS MADRE MESENQUIMALES
PRUEBA EXACTA DE FISHER
status_str publishedVersion
title Revisión sistemática del uso terapéutico de células madre mesenquimales en enfermedades musculoesqueléticas o neurodegenerativas en caninos
title_full Revisión sistemática del uso terapéutico de células madre mesenquimales en enfermedades musculoesqueléticas o neurodegenerativas en caninos
title_fullStr Revisión sistemática del uso terapéutico de células madre mesenquimales en enfermedades musculoesqueléticas o neurodegenerativas en caninos
title_full_unstemmed Revisión sistemática del uso terapéutico de células madre mesenquimales en enfermedades musculoesqueléticas o neurodegenerativas en caninos
title_short Revisión sistemática del uso terapéutico de células madre mesenquimales en enfermedades musculoesqueléticas o neurodegenerativas en caninos
title_sort Revisión sistemática del uso terapéutico de células madre mesenquimales en enfermedades musculoesqueléticas o neurodegenerativas en caninos
topic PATOLOGÍA MUSCULOESQUELÉTICA-CANINOS
CÉLULAS MADRE MESENQUIMALES
PRUEBA EXACTA DE FISHER
url http://dspace.udla.edu.ec/handle/33000/10990